Molecular Data News Today

The goal in highlighting this development is to attempt to raise awareness of the critical issue of information overload and the need for multiple involved parties to actively and aggressively search for appropriate, effective, and fiscally rational solutions.

While there are considerable barriers to incorporating comprehensive genotyping, the use of circulating tumor DNA offers an improvement in molecular testing—and doing so earlier can accelerate the time to treatment and improve survival for patients with lung cancer.

/PRNewswire/ -- Molecular Data, Inc. ("Molecular Data" or the "Company") (NASDAQ: MKD), a technology-driven platform in China, announced that it had received a...

/PRNewswire/ -- Molecular Data, Inc. ("Molecular Data" or the "Company") (NASDAQ: MKD), a technology-driven platform in China, announced that it had received a...

SHANGHAI, May 27, 2022 /PRNewswire/ -- Molecular Data, Inc. ("Molecular Data" or the "Company") MKD, a technology-driven platform in China, announced

Payoneer Global (NASDAQ:PAYO – Get Rating) and Molecular Data (NASDAQ:MKD – Get Rating) are both small-cap business services companies, but which is the better stock? We will compare the two businesses based on the strength of their analyst recommendations, profitability, earnings, dividends, valuation, risk and institutional ownership. Risk & Volatility Payoneer Global has a beta […]

Molecular Data Inc. (NASDAQ:MKD – Get Rating) was the recipient of a large decline in short interest during the month of May. As of May 15th, there was short interest totalling 423,500 shares, a decline of 93.4% from the April 30th total of 6,460,000 shares. Based on an average daily trading volume, of 1,260,000 shares, […]

/PRNewswire/ -- Molecular Data Inc. (NASDAQ: MKD) (the "Company") announced today a ratio change on its American Depositary Shares ("ADS") from the current one...

/PRNewswire/ -- Molecular Data Inc. (NASDAQ: MKD) (the "Company") announced today that on May 17, 2022, it received a Delinquency Compliance Plan Alert Letter...

Molecular Data Inc. (NASDAQ:MKD – Get Rating)’s stock is going to reverse split before the market opens on Monday, May 23rd. The 1-15 reverse split was announced on Monday, May 23rd. The number of shares owned by shareholders will be adjusted after the market closes on Monday, May 23rd. NASDAQ MKD traded down $0.04 during […]